In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate ...
NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.
The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...
A 74-year-old man with an active lifestyle and no family history of prostate cancer presented with mild urinary hesitancy and ...
Daily Mail on MSN
Massive 640% surge in prostate checks after Jeremy Clarkson went public with his cancer diagnosis
More than 50,000 used Prostate Cancer UK's online tool in the week since the former Top Gear host went public with his own diagnosis.
LOS ANGELES--(BUSINESS WIRE)--MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new ...
(Aging Untold) — Prostate cancer is one of the most common cancers for men in the United States, but deciding when to get screened isn’t always clear. While a PSA blood test can help find prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results